Welcome to Vaccines Conferences

A Vaccine can be defined as a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically consists of a disease-causative microorganism which is often prepared from killed or inactivated forms of the microbe, its toxins or one of its surface proteins. This agent stimulates the body's immune system to recognize it as threat, destroy it, and maintain a record of it, and any such successive similar infection can be more easily recognized by the immune system and destroyed.

Vaccines have been our best weapon against the world’s deadliest infectious diseases, including smallpox, polio, measles, and yellow fever. An effective virulent HIV vaccine would enable the body to fight with HIV virus and suppressing the symptoms of infection. Vaccines are the most powerful public health tools available and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic. A HIV vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years.


Upcoming Vaccines Conferences

Conferenceseries Destinations

Children Vaccines

Children Vaccines Conferences conference emphasizes on the theme- safety & efficacy of vaccination in children. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Polio VacMeningococcal Vaccines; Chicken pox (Varicella) Vaccines; Human Papillomavirus (HPV) Vaccine; Haemophilus influenza type b (Hib) Vaccine; Flu Vaccines; Rotavirus (RV) Vaccine;PPSV (Pneumococcal Vaccine); Hepatitis Vaccines; Immunization safety; Vaccine Storage and Handling; Entrepreneurs Investment Meetcines; Multiple vaccines (or) Combination Vaccines; Maternal Immunity; Bacterial Vaccines;

Vaccines Congress

Vaccines Congress will be organized with the theme -Innovative Therapeutic Strategies in Vaccines & Vaccination highlights the latest advancements and technologies in the field of Vaccination. The event discusses the available technologies in the vaccine development for the pandemic diseases and invites researchers and scientific personnel around the globe to share their novel scientific ideas and views related to the disease enhancing scope for further discoveries.

Vaccine development, Vaccines business, Novel Vaccines against Infectious Diseases, Adult Immunization Challenges, Diabetes Vaccines, Veterinary Vaccines, Therapeutic Vaccines for Chronic Infections, Cancer Vaccines / AIDS/HIV Vaccines, Immuno-Informatics in Vaccine Designs, Immunology / animal models, Vectors / adjuvants / drug delivery, Childhood Immunization Challenges, Vaccines for pregnant women
Vaccines Asia Pacific

Vaccines Asia Pacific Conferences which is to be held at Melbourne, Australia during November 10-12, 2016 hosted by Conference Series LLC through the theme "Discover and exploit emerging trends in vaccines and vaccination" conference will explore the advances in Vaccines and vaccination. This conference could be an exceptional event that brings along a novel and International mixture of giant and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Vaccines against Infectious diseases, Cancer Vaccines, Hepatitis Vaccines, Bacterial Vaccines, DNA Vaccines, Combination Vaccines, Edible vaccines, Viral vaccines, Vaccines against Vector borne Diseases, Travel Vaccines, Mosquito-borne Diseases-Vaccines, Protein Based Vaccines, Toxoid Vaccines, Geriatric Immunization, Immune mediated Diseases-Vaccines, Innovative Development of Vaccines, Mucosal vaccines, Child hood and maternal vaccines, Vaccines Industry, Vaccines for unconventional diseases, Developing Conjugate Vaccines, Plant Derived Vaccines, Vaccines for Pregnant women and Neonates, Animal Immunization.
IRDI Vaccines

H1N1 & Influenza Conferences highlights the theme “Advanced Technologies and Current Research in the field of H1N1 & Influenza Vaccines”. IRDI Vaccines 2016 takes an initiative to provide health practitioners an understanding about the vital role of H1N1 & Influenza vaccines in health and healing. The conferences also include prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Status of vaccines research and methodology, Influenza Virus -Immunology and Genetics Features, Transmission and Diagnosis of H1N1 Influenza Virus, Influenza Epidemiology and Diseases Management, Influenza Treatment & Therapies, H1N1 Influenza Vaccine, Recent Advancement in Influenza Vaccine, Market Analysis and Manufacturing Technologies, Ethical Issues in Pandemic Influenza Virus, Immunization against viral respiratory disease, Respiratory tract infections, Infections and Infectious Diseases, Respiratory Diseases, Vaccines and Therapeutics, Entrepreneurs Investment Meet

Conference Series LLC, a well-renowned scientific publisher and event organizer, proudly announces the commencement of Vaccines Conferences in 2016-17 in major countries of USA, Europe, Middle East and Asia-pacific with the support of 50,000 Editorial Board members of 700+ Open Access Journals. Vaccines meetings held at various locations of the world accommodate scientific symposia and workshops which are arranged in parallel to the scientific-sessions where issues are discussed on current research topics related to the conference main area or theme.

More than 50,000 people die in US each year from diseases that could have been prevented with a simple vaccine. Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017, for DNA Vaccines was valued at $305.3 million in 2014, and further to $2.7 billion by 2019, influenza market will grow from nearly $6 billion in 2018. The protein therapeutics market is expected to decline to $136.7 billion in 2013 and then increase too nearly $179.1 billion in 2018, for Multiple Sclerosis (MS) disease-modifying products is expected to grow to nearly $14.2 billion in 2018. A compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.

H1N1 flu is also known as swine flu. In 2009, H1N1 was spreading fast around the world. Since then, people have continued to get sick from swine flu. The best protection is to get a flu vaccine, or flu shot, every year. Swine flu is one of the viruses included in the vaccine. Conference Series LLC H1N1 & Influenza Vaccines Conference in USA discusses the available technologies in the vaccine development for this pandemic and invites researchers and scientific personnel around the globe to share their novel scientific ideas and views related to the disease enhancing scope for further discoveries.

Conference Series LLC Vaccines Conferences organizes Student fellowship program and Young Researcher’s forum thereby creating opportunities for students and Young researchers to share their research work at the front of broad International audience. Participating at these competitions involves research abstract submission and evaluation by the expert committee satisfying all conditions laid for the competition before the official acceptance into the program. The participants are informed about the status of their submission and further acceptance into the program. The poster-sessions will be evaluated by an expert panel where the best posters are awarded with certificate and memento recognizing their participation. Through these competitions, young researchers and students are able to gain confidence and also collaborate with the scientific audience at the conference.

Global Networking is a process of connecting individuals from diverse backgrounds into a single platform promoting information exchange which helps generating practical solutions to critical problems of importance. Conference Series LLC International Conferences provides unlimited scope for collaborations by gathering academicians from renowned universities and top most industrialists from business clusters to network on a same platform creating a channel for mutual associations and partnerships. CONFERENCE SERIES LLC International’s Vaccine Conferences are a major avenue for young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe.

Vaccine Meetings in 2016-17 will be organized in the major cities of United States of America, Europe, Middle East and Asia Pacific where the participants of the conference can explore the attractive tourist destinations as a part besides attending the event. The conference venues are decided in a way where multiple transportation options are available to reach the nearest airport. World-class Hospitality and accommodation will be provided to the registered participants endowing all luxuries and amenities at the conference venue itself.

Vaccines Associations and Societies

  • Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI)
  • Australasian Society of Clinical Immunology and Allergy 
  • Anaphylaxis Australia
  • Japanese Society for Immunology
  • Japanese Society of Allergology 
  • Malaysian Society of Allergy and Immunology 
  • Aha! Swiss Center for Allergy
  • Allergy & Allergies Agency (UK)
  • Anaphylaxis Campaign (UK)
  • Asociacíon Gallega de Asmáticos y Alérgicos
  • Asthma Society of Ireland Allergy UK
  • British Society for Allergy and Clinical Immunology
  • Danish Society for Allergology 
  • European Academy of Allergy and Clinical Immunology 
  • European Centre for Allergy Research Foundation
  • European Federation of Allergy and Airway Diseases Patients Associations
  • Federasma (Italy)
  • Allergy and Asthma Association of Health (Finland)
  • Fondation contre les Affectìons Respiratoires et pour l' Education à la Santé (F.A.R.E.S.)
  • Fondation pour la Prevention des Allergies
  • French Society of Allergology and Clinical Immunology 
  • German Rhinitis Study Group
  • German Society for Allergology and Clinical Immunology 
  • Hayfever Expert
  • Health on the Net Foundation (Switzerland)
  • Molecular Immunology
  • Nederlands Anafylaxis Netwerk
  • The Dutch Society for Allergology
  • Norges Astma- og Allergiforbund
  • Polish Allergen Research Center
  • Portuguese Society of Allergology and Clinical Immunology
  • Sociedad de Alergologos del Norte de España
  • Societat Catalana d'Al·lèrgia i Immunologia Clínica
  • Sociedad Española de Alergología e Inmunología Clínica
  • Swedish Association for Allergology 
  • Turkish National Society of Allergy and Clinical Immunology 
  • UCB Institute of Allergy
  • Argentine Association of Allergy and Immunology 
  • ARIA in Spanish
  • Brazilian Society of Allergy and Immunopathology 
  • Latin American Society of Allergy, Asthma & Immunology
  • Mexican College of Clinical Immunology and Allergy
  • Mexican College of Pediatricians specialists in Clinical immunonology & Allergy (COMPEDIA)
  • International Foundation for Asthma and Allergy (UNASMA)
  • Allergy and Asthma Network - Mothers of Asthmatics, Inc. (AAN-MA) (USA)
  • Allergy/Asthma Information Association (Canada)
  • Allergy Data Laboratories (Allergome Project)
  • MDLinx Allergy/Immunology
  • American Academy of Allergy, Asthma and Immunology
  • American College of Allergy, Asthma and Immunology
  • American Latex Association
  • American Lung Association
  • Anaphylaxis Network of Canada
  • Asthma and Allergy Foundation of America (AAFA)
  • Asthmamoms (USA)
  • Asthma Society of Canada
  • Canadian Society of Allergy and Clinical Immunology
  • Clinical Immunology Society
  • Federation of Clinical Immunology Societies (FOCiS)
  • Food Allergy and Anaphylaxis Network (FAN) (USA) 
  • Food Allergy Initiative (USA)
  • House Dustmite.org
  • Immune Deficiency Foundation (IDF) (USA)
  • National Institute of Allergy and Infectious Diseases (NIAID) (USA)
  • National Institutes of Health (NIH) (USA)
  • The New England Journal of Medicine
  • Best International Conferences

  • ACSET2015 - The Third Asian Conference, 21st to 25th October 2015, Kobe, Japan
  • SIGGRAPH Asia 2015, 2nd to 5th November 2015, Japan
  • 13th Asia Pacific Conference (APC2015), 8th November 2015, Beppu, Japan
  • New Jersey Immunization Conference, November 12 2015, New Jersey, USA
  • Immunization Symposium, November 12 2015, New Jersey, USA
  • Systems Immunology: From Molecular Networks to Human Biology (A1), January 10 - 14, 2016, Big Sky, Montana, USA
  • Cytokine JAK-STAT Signaling in Immunity and Disease (A2), January 10 - 14, 2016, Steamboat Springs, Colorado, USA
  • Viral Immunity (A2), January 11 - 16, 2016, Breckenridge, Colorado, USA
  • Integrating Metabolism and Tumor Biology (J1), January 13 - 18, 2016, Vancouver, British Columbia, Canada
  • PI 3-Kinase Signaling Pathways in Disease (J2), January 13 - 18, 2016, Vancouver, British Columbia, Canada
  • Immunity to Veterinary Pathogens: Informing Vaccine Development (A3), January 20 - 25, 2016, Keystone, Colorado, USA
  • Purinergic Signaling (J5), January 24 - 28, 2016, Vancouver, British Columbia, Canada
  • Cancer Immunotherapy: Immunity and Immunosuppression Meet Targeted Therapies (J6), January 24 - 28, 2016, Vancouver, British Columbia, Canada
  • Cell Biology and Immunology of Persistent Infection (A8), January 31 - February 4, 2016, Banff, Alberta, Canada
  • Cell Biology and Immunology of Persistent Infection (A8), January 31 - February 4, 2016, Banff, Alberta, Canada
  • Stromal Cells in Immunity (Q4), February 7 - 11, 2016, Keystone, Colorado, USA
  • Obesity and Adipose Tissue Biology (B2), February 15 - 19, 2016, Banff, Alberta, Canada
  • Immunometabolism in Immune Function and Inflammatory Disease (Q8), February 21 - 25, 2016, Banff, Alberta, Canada
  • T Follicular Helper Cells and Germinal Centers (B4), February 26 - March 1, 2016, Monterey, California, USA
  • Immunity in Skin Development, Homeostasis and Disease (B5), February 28 - March 2, 2016, Tahoe City, California, USA
  • Tuberculosis Co-Morbidities and Immunopathogenesis (B6), February 28 - March 3, 2016, Keystone, Colorado, USA
  • Cancer Vaccines: Targeting Cancer Genes for Immunotherapy (X1), March 6 - 10, 2016, Whistler, British Columbia, Canada
  • Antibodies as Drugs (X2), March 6 - 10, 2016, Whistler, British Columbia, Canada
  • NF-kappaB and MAP Kinase Signaling in Inflammation (X4), March 13 - 17, 2016, Whistler, British Columbia, Canada
  • Chromatin and Epigenetics (C2), March 20 - 24, 2016, Whistler, British Columbia, Canada
  • HIV Persistence: Pathogenesis and Eradication (X7), March 20 - 24, 2016, Olympic Valley, California, USA
  • HIV Vaccines (X8), March 20 - 24, 2016, Olympic Valley, California, USA
  • World Vaccine Congress US 2016, March 29 - 31 2016, Grand Hyatt, Washington D.C., USA
  • Positive-Strand RNA Viruses (N1), May 1 - 5, 2016, Austin, Texas, USA
  • Nucleic Acid Sensing Pathways: Innate Immunity, Immunobiology and Therapeutics (E2), May 8 - 12, 2016, Dresden, Germany
  • Immunology 2016™, May 13-17 2016, Seattle, WA
  • New Approaches to Vaccines for Human and Veterinary Tropical Diseases (M1), May 22 - 26, 2016, Cape Town, South Africa
  • B Cells at the Intersection of Innate and Adaptive Immunity (E3), May 29 - June 2, 2016, Stockholm, Sweden
  • Autophagy: Molecular and Physiological Mechanisms (V1), June 5 - 9, 2016, Whistler, British Columbia, Canada
  • Microglia in the Brain immunology(Z4), June 12 - 16, 2016, Keystone, Colorado, USA
  • The 16th International Congress of Immunology - ICI 2016, August 21 –26 2016, Melbourne, Australia
  • The Modes of Action of Vaccine Adjuvants (S1), October 8 - 13, 2016, Seattle, Washington, USA
  • Translational Vaccinology for Global Health (S1), October 26 - 30, 2016, London, United Kingdom
  • Cell Death Signaling in Cancer and the Immune System (S2), October 28 - November 2, 2016, Guarujá, São Paulo, Brazil
  • The EFIS-EJI Ruggero Ceppellini Advanced School of Immunology - "Treg Cell Biology and Metabolism", November 05 -06 2016, Naples, Italy
  • TGF-ß in Immunity, Inflammation and Cancer (A3), January 9 - 13, 2017, Taos, New Mexico, USA
  • PI3K Pathways in Immunology, Growth Disorders and Cancer (A6), January 15 - 19, 2017, Santa Fe, New Mexico, USA
  • Viral Immunity: Mechanisms and Consequences (B4), February 19 - 23, 2017, Santa Fe, New Mexico, USA
  • Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology (C7), March 19 - 23, 2017, Whistler, British Columbia, Canada
  • Pattern Recognition Signaling: From Innate Immunity to Inflammatory Disease (X5), March 19 - 23, 2017, Banff, Alberta, Canada
  • Immune Regulation in Autoimmunity and Cancer (D1), March 26 - 30, 2017, Whistler, British Columbia, Canada
  • T Follicular Helper Cells and Germinal Centers (B4), February 26 - March 1, 2016, Monterey, California, USA
  • Mononuclear Phagocytes in Health, Immune Defense and Disease (D3), April 30 - May 4, 2017, Austin, Texas, USA
  • Modeling Viral Infections and Immunity (E1), May 1 - 4, 2017, Estes Park, Colorado, USA
  • Integrating Metabolism and Immunity (E4), May 29 - June 2, 2017, Dublin, Ireland